Financial News
Articles published by Applied DNA Sciences, Inc.
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
February 24, 2022
Via Business Wire
Tickers
APDN
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
February 22, 2022
Via Business Wire
Tickers
APDN
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
February 10, 2022
Via Business Wire
Tickers
APDN
Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
January 28, 2022
Via Business Wire
Tickers
APDN
Applied DNA Announces Continued Momentum in COVID-19 Testing Demand
January 18, 2022
Via Business Wire
Tickers
APDN
Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance
December 06, 2021
Via Business Wire
Tickers
APDN
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel
October 25, 2021
Via Business Wire
Tickers
APDN
Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain
October 20, 2021
Via Business Wire
Tickers
APDN
Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College
October 12, 2021
Via Business Wire
Tickers
APDN
Via Business Wire
Tickers
APDN
Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021
Via Business Wire
Tickers
APDN
Via Business Wire
Tickers
APDN
Applied DNA Announces Third Quarter Fiscal 2021
August 12, 2021
Via Business Wire
Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract
August 03, 2021
Via Business Wire
Tickers
APDN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.